Literature DB >> 23088931

Cardiac findings and long-term thromboembolic outcomes following pulmonary embolism in children: a combined retrospective-prospective inception cohort study.

Hayley S Hancock1, Michael Wang, Katja M Gist, Elizabeth Gibson, Shelley D Miyamoto, Peter M Mourani, Marilyn J Manco-Johnson, Neil A Goldenberg.   

Abstract

In paediatric pulmonary embolism, cardiac findings and thromboembolic outcomes are poorly defined. We conducted a mixed retrospective-prospective cohort study of paediatric pulmonary embolism at the Children's Hospital Colorado between March, 2006 and January, 2011. A total of 58 consecutive children - age less than or equal to 21 years - with acute pulmonary embolism were enrolled. Data collection included clinical and laboratory characteristics, treatments, serial echocardiographic and electrocardiographic findings, and outcomes of pulmonary embolism non-resolution and recurrence. The median age was 16.5 years ranging from 0 to 21 years. The most prevalent clinical risk factors were oral contraceptive pill use (52% of female patients), presence of a non-infectious inflammatory condition (21%), and trauma (21%). Thrombophilias included heterozygous factor V Leiden in 21%; antiphospholipid antibody syndrome was established in 31% overall. Proximal pulmonary artery involvement was present in 34%. At presentation, nearly half of the patients had hypoxaemia and 37% had tachycardia. The classic electrocardiographic finding of S1Q3T3 was present in 12% acutely; tricuspid regurgitation greater than 3 metres per second, septal flattening, and right ventricular dilation were each present on acute echocardiogram in 25%. Nearly all patients received therapeutic anticoagulation, with initial systemic tissue plasminogen activator administered in 16% for occlusive iliofemoral deep venous thrombosis and/or massive pulmonary embolism. Pulmonary embolism resolution was observed in 82% by 6 months. Recurrent pulmonary embolism occurred in 9%. There were no pulmonary embolism-related deaths. Right ventricular dysfunction was rare in follow-up. These data indicate that acute heart strain is common, but chronic cardiac dysfunction is rare, following aggressive management of acute pulmonary embolism in children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23088931     DOI: 10.1017/S1047951112001126

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  6 in total

1.  Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study.

Authors:  Christie M Atchison; Shilpa Arlikar; Ernest Amankwah; Irmel Ayala; Laurie Barrett; Brian R Branchford; Michael Streiff; Clifford Takemoto; Neil A Goldenberg
Journal:  J Pediatr       Date:  2014-07-23       Impact factor: 4.406

2.  A case of panic to pulmonary embolism.

Authors:  Mansum Ng; Nikila Pandya; Brendon Conry; Richard Gale
Journal:  BMJ Case Rep       Date:  2015-06-12

3.  Gene Expression Profiling of Pulmonary Artery in a Rabbit Model of Pulmonary Thromboembolism.

Authors:  Zhiyuan Tang; Xudong Wang; Jianfei Huang; Xiaoyu Zhou; Hao Xie; Qilin Zhu; Minjie Huang; Songshi Ni
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

Review 4.  Pulmonary Embolism in Children.

Authors:  Ahmar Urooj Zaidi; Kelley K Hutchins; Madhvi Rajpurkar
Journal:  Front Pediatr       Date:  2017-08-10       Impact factor: 3.418

5.  Risk factors for the development of hospital-acquired pediatric venous thromboembolism-Dealing with potentially causal and confounding risk factors using a directed acyclic graph (DAG) analysis.

Authors:  Leonardo Rodrigues Campos; Maurício Petroli; Flavio Roberto Sztajnbok; Elaine Sobral da Costa; Leonardo Rodrigues Brandão; Marcelo Gerardin Poirot Land
Journal:  PLoS One       Date:  2020-11-13       Impact factor: 3.240

Review 6.  Pulmonary embolism in children, a real challenge for the pediatrician: a case report and review of the literature.

Authors:  Alessandra Maggio; Lilia Altieri; Dario Pantaleo; Michela Grignani; Lidia Decembrino
Journal:  Acta Biomed       Date:  2022-06-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.